ExploreWatchlistsPricing
  1. US-listed companies
  2. Sonnet BioTherapeutics Holdings, Inc.
  3. Financials
  4. Total liabilities

Sonnet BioTherapeutics Holdings, Inc. (SONN)

Market cap
$1.26
P/E ratio
SummaryFinancials
Period EndTotal liabilities (Million USD)YoY (%)
Sep 30, 20254+25.80%
Sep 30, 20243-42.41%
Sep 30, 20236-32.42%
Sep 30, 20228+24.28%
Sep 30, 20217+35.37%
Sep 30, 20205-85.66%
Dec 31, 201935+61.06%
Dec 31, 201822+15.20%
Dec 31, 201719-5.50%
Dec 31, 201620-3.26%
Dec 31, 201520-1.78%
Dec 31, 201421+135.29%
Dec 31, 20139

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat